| PACKAGING TYPE: | 20x10 Blister (20 Strips In 1 Box) |
| COMPOSITION: | Glimepiride (1mg) + Metformin (500mg) (sr) + Pioglitazone (15mg) (double Color) |
| FORMULATION: | Tablet |
| Description: | MEPRIMET P 1 Tablet is a triple-combination antidiabetic medication containing: Glimepiride 1mg – a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. Metformin (SR) 500mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity, with sustained-release action for prolonged effect. Pioglitazone 15mg – a thiazolidinedione that enhances insulin sensitivity in peripheral tissues. This combination is used for the management of Type 2 Diabetes Mellitus, especially in patients requiring triple therapy for better glycemic control. It targets multiple pathways involved in glucose metabolism, providing comprehensive and sustained blood sugar control. |
| Side Effects: | Common side effects: Nausea or gastrointestinal discomfort Weight gain (due to Pioglitazone) Headache Hypoglycemia Rare but serious side effects: Lactic acidosis (rare, due to Metformin) Fluid retention or edema Liver function abnormalities Severe hypoglycemia Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take MEPRIMET P 1 Tablet orally, usually once daily with meals or as prescribed. Swallow the tablet whole; do not crush or chew (SR formulation). Do not skip meals to avoid hypoglycemia. Maintain a healthy diet and regular exercise routine. Monitor blood glucose levels regularly. |
| Precaution: | Monitor for symptoms of hypoglycemia (sweating, dizziness, confusion). Use cautiously in patients with heart failure (due to Pioglitazne). Avoid excessive alcohol consumption (risk of lactic acidosis). Use with caution in kidney and liver impairment. Inform your doctor about all medications to avoid interactions. Not recommended during pregnancy or breastfeeding without medical advice. |
| Product Benefits: | Provides triple-action blood glucose control. Helps reduce fasting and postprandial sugar levels. Improves insulin secretion and insulin sensitivity. Sustained-release Metformin ensures prolonged glucose control. Reduces risk of long-term diabetic com |
Frequently Asked Questions
It is used to manage Type 2 Diabetes Mellitus with triple-drug therapy for better control.
It provides gradual and prolonged glucose control with fewer gastrointestinal side effects.
Yes, Pioglitazone may cause weight gain or fluid retention.










